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action, studies on both salt-sensitive rats and human salt-
sensitive hypertension5 have indicated the natriuretic role
of 20-HETE was closely related to high salt intake. It is not
clear in vivo whether the expression site of CYP4F2 is the
only place where 20-HETE works, or whether 20-HETE
could diffuse into the local and systemic circulation as
well. Detailed mechanisms underlying the hypertension
pathogenesis in our TG model have not been illustrated
yet, which therefore urged us to study further. Recently, we
induced 20-HETE synthesis by androgen in TG mice
and confirmed the prohypertensive role of 20-HETE
(not published). We are now investigating the natriuresis
of 20-HETE by feeding TG mice a high-salt diet.
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To the Editor: We read with interest the report on global
activity in live-donor kidney donation.1 However, we must
highlight a possible misinterpretation of the data therein. The
country of Saudi Arabia is presented as having the highest
reported living kidney donor transplant rate, at 32 per
million population (p.m.p.). From the annual report of the
Saudi Centre for Organ Transplantation2 (SCOT), it is clear
that only 260 transplants were performed in the country
in 2007 using live-donor kidneys. The rate is therefore
10.1 p.m.p. The SCOT report identifies—with laudable
transparency—an additional 597 kidney transplantations
carried out abroad on Saudi citizens. Undoubtedly, the
majority of these cases constitute unethical transplant
tourism. The SCOT data reveal Saudi Arabia’s admirable
progress toward national self-sufficiency through its
increasing self-reliance in organ procurement. Since 2005,
the number of patients transplanted abroad has steadily
decreased and deceased-donor organ donations have in-
creased to unprecedented levels. The Saudi authorities are
clearly taking responsibility for meeting the transplantation
needs of citizens and residents in the country, thereby
minimizing the harmful effects of transplant tourism.
The pursuit of self-sufficiency in organs for transplan-
tation is the only way to progress toward global justice in
transplantation. Responding to national organ needs avoids
predatory behavior at the expense of underprivileged popu-
lations in other countries. Although increased rates of living
donation in many countries are a positive sign of public
support for transplantation, caution is required when inter-
preting such information.
1. Horvat LD, Shariff SZ, Garg AX. Global trends in the rates of living
kidney donation. Kidney Int 2009; 75: 1088–1098.
2. Saudi Centre for Organ Transplantation. Available at
http://www.scot.org.sa/annual-report.html
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We appreciate the careful reading of our article by Dr Noel,
who raises a valid point regarding kidney transplant activity
in Saudi Arabia.1 The Saudi Centre for Organ Transplanta-
tion reports both living related and unrelated kidney
transplants, a division which is clearly presented in our
Supplementary Table S2 available online.2 In 2006, we
reported 200 kidney transplants performed from living
related donors in Saudi Arabia, whereas 646 kidney
transplants were attributed to living unrelated donors. As
Dr Noel justly points out, some of these unrelated living
kidney donor transplants might reflect unethical transplant
tourism activity. Saudi Arabian data should be interpreted
with this information in mind. Nevertheless, it was our
intent to quantify living kidney donor transplant activity
internationally; as such, these figures could not be ignored.
The fact remains that rates of living kidney donation have
been increasing worldwide. Our report represents the most
comprehensive international summary of living kidney
donor rates to date, and enables transplant professionals
worldwide to put their rates into a global context.
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On a broader note, Dr Noel highlights a point with
which we could not agree with more: national self-
sufficiency in organ transplantation is needed to
combat organ tourism and achieve global justice in
transplantation. As the Declaration of Istanbul on Organ
Trafficking and Transplant Tourism suggests, national
governments have a responsibility to monitor their
transplant activity, prohibiting unethical transplant
practices.3
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To the Editor: Matsui et al.1 have nicely demonstrated
a fetuin-containing mineral complex in adenine-treated rats
with renal failure that is prevented by alendronate treatment.
However, the conclusion that this is related to, or is a marker
of vascular calcification is premature. The presence of this
complex is not surprising considering the extremely high
circulating phosphate levels that occur in this model. In
addition, the failure to control pH during the preparation of
the serum almost certainly increased these complexes because
of the reduced solubility in alkaline solution. We routinely
dilute our plasma samples immediately after they are
obtained in order to prevent precipitation of calcium and
phosphate. The absence of the complexes in alendronate-
treated rats can easily be explained by the significantly lower
calcium concentration, which, as was shown by the authors,
has a major impact on complex formation. The inhibition of
vascular calcification is probably due to a direct inhibition as
we have shown for bisphosphonates in cultured aortas.2 The
formation of the mineral complexes is probably just a
physicochemical phenomenon related to ambient phosphate
and calcium levels. Their correlation with vascular calcifica-
tion can be explained by the fact that calcium and phosphate
levels also affect vascular calcification, rather than by a direct
pathophysiological link.
1. Matsui I, Hamano T, Mikami S et al. Fully phosphorylated fetuin-A forms a
mineral complex in the serum of rats with adenine-induced renal failure.
Kidney Int 2009; 75: 915–918.
2. Lomashvili KA, Monier-Faugere M-C, Wang X et al. Effect of
bisphosphonates on vascular calcification and bone metabolism in
experimental renal failure. Kidney Int 2009; 75: 617–625.
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We thank Dr O’Neill for his interest in our study and his
comments1 on our article.
We previously showed that serum fetuin-A concentra-
tions were not significantly associated with coronary artery
calcification scores in diabetic chronic kidney disease
patients.2 Therefore, we tried to elucidate whether low
serum fetuin-A levels really correlate with vascular
calcification in animal models. Renal failure model rats
showed that not serum fetuin-A concentrations but
fetuin–mineral complex (FMC) correlated with the extent
of vascular calcification.3 This complex was not observed
in rats without vascular calcification. As we only found the
association between FMC and vascular calcification in rats
with adenine-induced renal failure, further investigation
must be carried out to assert that FMC is a marker of
vascular calcification stress.
Serum pH levels might affect FMC formation. As we did
not control pH during serum preparation,3 we measured
the pH of residual serum samples. Serum pH was
7.762±0.119 in control rats, 7.691±0.088 in adenine rats
at 2 weeks, 7.583±0.045 at 4 weeks, and 7.614±0.062 at 5
weeks. Although the addition of 1M Tris-HCl (pH 7.2) to
these serum samples decreased pH, we found similar FMC
in pH-modified adenine rat serum (data not shown). This
preliminary result suggests that FMC can exist in serum
without alkalemia.
We showed that injection of alendronate to adenine rats
reduced FMC, followed by the inhibition of vascular
calcification. Lomashvili et al.4 demonstrated well the
mechanism by which bisphosphonates prevent medial
vascular calcification. They showed that etidronate and
pamidronate can directly inhibit vascular calcification
independent of bone resorption.4 It is possible that
alendronate also directly functioned in our model.
However, the changes in serum/plasma calcium levels by
bisphosphonate administration suggest another mechan-
ism. Alendronate decreased serum calcium in our experi-
ment, but etidronate and pamidronate did not in
Lomashvili’s experiments,4 except for the highest etidro-
nate group. This difference may indicate that bone
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